Correction to: Cancer Gene Therapy https://doi.org/10.1038/s41417-018-0064-8

The authors wish to notify the readers of the following change: In “Depletion of ERCC6L induces apoptosis” section, in the sentence “The percentages of apoptotic cells in the sh-ERCC6L and sh-Ctrl groups were 8.33% and 3.80% respectively (P < 0.01) and 9.29% and 3.94% respectively (P < 0.01) in the 786-O cells and Caki-1 cells (Fig. 2G)”; the percentages of apoptotic cell in the sh-ERCC6L and sh-Ctrl groups in the 786-0 cells should be “8.46% and 5.02%” and the P value should be “P < 0.05”. Figure 2G, left panel, the above two graphs of flow cytometry of 786-0 cells should be replaced by the correct graphs, and in the right panel, the left two columns representing apoptotic cells of 786-0 cells should be replaced by those representing the correct number of apoptotic cells of 786-0 cells. Finally, at the end of “Fig. 2” legend, “*P < 0.05” should be added before the last sentence “P < 0.01”.

The authors apologize for these errors. The reason for these errors to occur is that the authors mixed up the flow cytometry results of 786-0 cells with Caki-1 cells when they analyzed the data. The flow cytometry results of 786-0 cells in Fig. 2G in the original published paper were mistakenly used instead of the still flow cytometry results of Caki-1 cells. After checking the raw data of these two cells, the authors found the flow cytometry results of 786-0 cells and made a re-analysis.

The original article has been corrected.